Nov 21 (Reuters) - GlaxoSmithKline Plc GSK.L :
* GSK files regulatory submission of candidate vaccine for prevention of shingles in Canada
* Says regulatory submission for candidate shingles vaccine is based on a comprehensive phase III clinical trial program Source text for Eikon: ID:nCNWdtfrBa Further company coverage: GSK.L